The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss

Journal of Cellular Physiology

Volumn 227, Issue 7, 2012, Pages 2889-2897

  Shandala, Tetyana ^a,b   Shen Ng, Yeap ^a   Hopwood, Blair ^a   Yip, Yuen Ching ^a   Foster, Bruce K ^a   Xian, Cory J ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; F ACTIN; INTERLEUKIN 11; INTERLEUKIN 6; MESSENGER RNA; METHOTREXATE; PHOSPHATASE; TARTARIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CELL CULTURE; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DENDRITE; GENE EXPRESSION; HEMATOPOIETIC CELL; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MALE; METAPHYSIS; NONHUMAN; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIBIA; TRABECULAR BONE;

ACID PHOSPHATASE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BONE RESORPTION; CASPASE 3; CELL DIFFERENTIATION; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR MATRIX PROTEINS; HOMEOSTASIS; INTERLEUKIN-11; INTERLEUKIN-6; ISOENZYMES; MALE; METHOTREXATE; NEOPLASMS; OSTEOCLASTS; OSTEOCYTES; OSTEOGENESIS; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 84858640764     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23034     Document Type: Article

References (48)

1. Ahmed MM, Sells SF, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Harp C, Mohiuddin M, Rangnekar VM. 1997. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. J Biol Chem 272: 33056-33061.
2. Ahuja SS, Zhao SJ, Bellido T, Plotkin LI, Jimenez F, Bonewald LF. 2003. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144: 1761-1769.
3. Bonewald LF. 1999. Establishment and characterization of an osteocyte-like cell line, MLO-Y4. J Bone Miner Metab 17: 61-65.
4. Boyce BF, Yao Z, Xing L. 2009. Osteoclasts have multiple roles in bone in addition to bone resorption. Crit Rev Eukaryot Gene Expr 19: 171-180.
5. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
6. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. 2007. Glucocorticoid-induced osteoporosis: Pathophysiology and therapy. Osteoporos Int 18: 1319-1328.
7. Cardoso L, Herman BC, Verborgt O, Laudier D, Majeska RJ, Schaffler MB. 2008. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res 24: 597-605.
8. Chabner BA, Roberts TG, Jr. 2005. Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer 5: 65-72.
9. Fan C, Cool JC, Scherer MA, Foster BK, Shandala T, Tapp H, Xian CJ. 2009. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment. Bone 44: 61-70.
10. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE. 2006. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38: 1310-1315.
11. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ. 2006. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 7: 813-820.
12. Georgiou KR, Scherer MA, Fan CM, Cool JC, King TJ, Foster BK, Xian CJ. 2011. Methotrexate chemotherapy reduces osteogenesis but increases adipogenesis potential in the bone marrow. J Cell Physiol DOI 10.1002/jcp.22807
13. Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR. 1996. Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 335: 1041-1048.
14. Guicciardi ME, Gores GJ. 2009. Life and death by death receptors. FASEB J 23: 1625-1637.
15. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S, Barr RD. 1996. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11: 1774-1783.
16. Heino TJ, Kurata K, Higaki H, Vaananen HK. 2009. Evidence for the role of osteocytes in the initiation of targeted remodeling. Technol Health Care 17: 49-56.
17. Hernandez CJ, Majeska RJ, Schaffler MB. 2004. Osteocyte density in woven bone. Bone 35: 1095-1099.
18. Hoebertz A, Arnett T. 2003. Isolated osteoclast culture. Helfrich M, Ralston S, editors. Bone research protocols. Totowa, NJ: Humana Press. pp 53-64.
19. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF. 1997. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res 12: 2014-2023.
20. Ko S, Harris SE, Dallas M, Bonewald LF. 2003. MLO-Y4 cells produce an unknown chemoattrantant for osteoclast precursors. J Bone Miner Res 18: S150-S150.
21. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191: 275-286.
22. Kogianni G, Noble BS. 2007. The biology of osteocytes. Curr Osteoporos Rep 5: 81-86.
23. Kogianni G, Mann V, Ebetino F, Nuttall M, Nijweide P, Simpson H, Noble B. 2004. Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci 75: 2879-2895.
24. Kogianni G, Mann V, Noble BS. 2008. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res 23: 915-927.
25. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H. 2004. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200: 941-946.
26. Kurata K, Heino TJ, Higaki H, Vaananen HK. 2006. Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture. J Bone Miner Res 21: 616-625.
27. Marshall D, Helfrich M, Aspden R. 2003. Scanning electron microscopy of bone. Helfrich M, Ralston S, editors. Bone research protocols. Totowa, NJ: Humana Press. pp 311-322.
28. Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, Joensuu T, van Leeuwen FE, van't Veer MB, Curtis RE, Holowaty EJ, Andersson M, Wiklund T, Gospodarowicz M, Travis LB. 2000. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18: 2435-2443.
29. Noble B. 2003a. Bone microdamage and cell apoptosis. Eur Cell Mater 6: 46-55.
30. Noble B, Stevens H. 2003b. Techniques for the study of apoptosis in bone. Helfrich M, Ralston S, editors. Bone reserach protocols. Totowa, NJ: Humana Press. pp 225-236.
31. Schriock EA, Schell MJ, Carter M, Hustu O, Ochs JJ. 1991. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol 9: 400-405.
32. Scutt A, Reading L, Scutt N, Still K. 2003. Mineralizing fibroblast-colony-forming assays. Helfrich M, Ralston S, editors. Bone research protocols. Totowa, NJ: Humana Press. pp 29-39.
33. Seeman E. 2006. Osteocytes-Martyrs for integrity of bone strength. Osteoporos Int 17: 1443-1448.
34. Sims NA, Jenkins BJ, Nakamura A, Quinn JM, Li R, Gillespie MT, Ernst M, Robb L, Martin TJ. 2005. Interleukin-11 receptor signaling is required for normal bone remodeling. J Bone Miner Res 20: 1093-1102.
35. Takahashi N, Udagawa N, Tanaka S, Suda T. 2003. Generating murine osteoclasts from bone marrow. Methods Mol Med 80: 129-144.
36. Tomkinson A, Gevers EF, Wit JM, Reeve J, Noble BS. 1998. The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 13: 1243-1250.
37. Tsangari H, Findlay DM, Kuliwaba JS, Atkins GJ, Fazzalari NL. 2004. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 35: 334-342.
38. Tsuji M, Ikeda H, Ishizu A, Miyatake Y, Hayase H, Yoshiki T. 2006. Altered expression of apoptosis-related genes in osteocytes exposed to high-dose steroid hormones and hypoxic stress. Pathobiology 73: 304-309.
39. Verborgt O, Tatton NA, Majeska RJ, Schaffler MB. 2002. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: Complementary roles in bone remodeling regulation? J Bone Miner Res 17: 907-914.
40. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA. 2003. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22: 6267-6276.
41. Xian CJ, Howarth GS, Cool JC, Foster BK. 2004. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats. Bone 35: 739-749.
42. Xian CJ, Cool JC, Pyragius T, Foster BK. 2006. Damage and recovery of the bone growth mechanism in young rats following 5-fluorouracil acute chemotherapy. J Cell Biochem 99: 1688-1704.
43. Xian CJ, Cool JC, Scherer MA, Macsai CE, Fan C, Covino M, Foster BK. 2007a. Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects. Bone 41: 842-850.
44. Xian CJ, Cool JC, van Gangelen J, Foster BK, Howarth GS. 2007b. Effects of etoposide and cyclophosphamide acute chemotherapy on growth plate and metaphyseal bone in rats. Cancer Biol Ther 6: 170-177.
45. Xian CJ, Cool JC, Scherer MA, Fan C, Foster BK. 2008. Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells. J Cell Physiol 214: 777-785.
46. Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, Lane NE. 2008. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum 58: 1674-1686.
47. Zhang KQ, Barragan-Adjemian C, Ye L, Kotha S, Dallas M, Lu YB, Zhao SJ, Harris M, Harris SE, Feng JQ, Bonewald LF. 2006. E11/gp38 selective expression in osteocytes: Regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol 26: 4539-4552.
48. Zhao S, Kato Y, Zhang Y, Harris S, Ahuja SS, Bonewald LF. 2002. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res 17: 2068-2079.